Prevalence of Unknown Hyperglycemia in Oral Surgery Patients in Dental Clinics

Lizzett López-Yee¹, Gisela Pineda-García², Betsabé DeLaCruz-Corona¹ and Fernanda Araiza-Verduzco^1,

¹Faculty of Dentistry, Autonomous University of Baja California (UABC), Tijuana, Mexico

²Faculty of Medicine and Psychology, Autonomous University of Baja California (UABC), Tijuana, Mexico

Cite this paper

Lizzett López-Yee, Gisela Pineda-García, Betsabé DeLaCruz-Corona and Fernanda Araiza-Verduzco. Prevalence of Unknown Hyperglycemia in Oral Surgery Patients in Dental Clinics. International Journal of Dental Sciences and Research. 2024; 12(1):9-12. doi: 10.12691/IJDSR-12-1-2

Abstract

Hyperglycemia is a condition in which an excessive amount of glucose circulate in the blood plasma. This condition could have severe repercussions in the healing processes and exacerbate preexisting and future conditions such as periodontic or vascular related. Therefore, it is vital for the dental professional to know the glycemic indexes of their patients; however, it is not a common practice, in addition, in Mexico it’s not common practice for patients to know their own glycemic rages, this could lead to prolonged bleeding, long healing times and vascular consequences. In this research we evaluated the glycemic indexes of 100 patients with no previous knowledge or suspicious of diabetes or hyperglycemia using two methods of evaluation, glucometer and laboratory test. The result showed that 19% of the patients exhibited diabetic levels of hyperglycemia and didn’t know about it, proving the importance of knowing the patients’ glycemic indexes by any method to assure improved integral treatment dental clinics.

Keywords

hyperglycemia, diabetes prevalence, preventive dentistry

Copyright

This work is licensed under a Creative Commons Attribution 4.0 International License. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/

References

[1]	Marik PE, Egi M. Treatment thresholds for hyperglycemia in critically ill patients with and without diabetes. Intensive Care Medicine. 2014; 40(7): 1049-51.
[2]	Tuomi T, Santoro N, Caprio S, Cai M, Weng J, Groop L. The many faces of diabetes: a disease with increasing heterogeneity. Lancet (London, England). 2014; 383(9922): 1084-94.
[3]	Tinajero MG, Malik VS. An Update on the Epidemiology of Type 2 Diabetes: A Global Perspective. Endocrinology and Metabolism Clinics of North America. 2021; 50(3): 337-55.
[4]	Simon K, Wittmann I. Can blood glucose value really be referred to as a metabolic parameter? Rev Endocr Metab Disord. 2019; 20(2): 151-60.
[5]	Shi J, Dong B, Mao Y, Guan W, Cao J, Zhu R, et al. Review: Traumatic brain injury and hyperglycemia, a potentially modifiable risk factor. Oncotarget. 2016; 7(43): 71052-61.
[6]	Fathallah N, Slim R, Larif S, Hmouda H, Ben Salem C. Drug-Induced Hyperglycaemia and Diabetes. Drug Saf. 2015; 38(12): 1153-68.
[7]	Marik PE, Bellomo R. Stress hyperglycemia: an essential survival response! Crit Care. 2013; 17(2): 305.
[8]	Jellinger PS. Metabolic consequences of hyperglycemia and insulin resistance. Insulin. 2009; 4(1): 2-14.
[9]	Coursin DB, Connery LE, Ketzler JT. Perioperative diabetic and hyperglycemic management issues. Critical Care Medicine. 2004; 32(4).
[10]	Makris K, Spanou L. Is there a relationship between mean blood glucose and glycated hemoglobin? J Diabetes Sci Technol. 2011; 5(6): 1572-83.
[11]	Forouhi NG, Wareham NJ. Epidemiology of diabetes. Medicine. 2010; 38(11): 602-6.
[12]	Baltzis D, Eleftheriadou I, Veves A. Pathogenesis and Treatment of Impaired Wound Healing in Diabetes Mellitus: New Insights. Advances in Therapy. 2014; 31(8): 817-36.
[13]	Davies MJ, D'Alessio DA, Fradkin J, Kernan WN, Mathieu C, Mingrone G, et al. Management of Hyperglycemia in Type 2 Diabetes, 2018. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetes Care. 2018; 41(12): 2669-701.
[14]	Zelihic E, Poneleit B, Siegmund T, Haller B, Sayk F, Dodt C. Hyperglycemia in emergency patients--prevalence and consequences: results of the GLUCEMERGE analysis. Eur J Emerg Med. 2015; 22(3): 181-7.
[15]	Carpenter DL, Gregg SR, Xu K, Buchman TG, Coopersmith CM. Prevalence and Impact of Unknown Diabetes in the ICU. Critical Care Medicine. 2015; 43(12).
[16]	Harase T, Nishida W, Hamakawa T, Hino S, Shigematsu K, Kobayashi S, et al. Clinical implication of blood glucose monitoring in general dental offices: the Ehime Dental Diabetes Study. BMJ Open Diabetes Research & Care. 2015; 3(1): e000151.
[17]	Dubey RK, Gupta DK, Singh AK. Dental implant survival in diabetic patients; review and recommendations. Natl J Maxillofac Surg. 2013; 4(2): 142-50.
[18]	Kocher T, König J, Borgnakke WS, Pink C, Meisel P. Periodontal complications of hyperglycemia/diabetes mellitus: Epidemiologic complexity and clinical challenge. Periodontology 2000. 2018; 78(1): 59-97.
[19]	Holmes H, Negi M, Stephen LXG. Diabetic status of patients presenting for dental treatment. South African Dental Journal. 2018; 73(4): 274-7.
[20]	Jadhav A, Tarte P, Puri S. Dental clinic: Potential source of high-risk screening for prediabetes and type 2 diabetes. Indian Journal of Dental Research. 2019; 30(6): 851-4.
[21]	Basto-Abreu AC, López-Olmedo N, Rojas-Martínez R, Aguilar-Salinas CA, De la Cruz-Góngora VV, Rivera-Dommarco J, et al. Prevalence of diabetes and glycemic control in Mexico: national results from 2018 and 2020. Salud Publica Mex. 2021; 63(6, Nov-Dic): 725-33.
[22]	Dávila-Cervantes CA, Agudelo-Botero M. Sex disparities in the epidemic of type 2 diabetes in Mexico: national and state level results based on the Global Burden of Disease Study, 1990-2017. Diabetes Metab Syndr Obes. 2019; 12: 1023-33.
[23]	Harada Y, Harada K, Chin P, Jr. Comparing Self Monitoring Blood Glucose Devices and Laboratory Tests: Over 25 Years Experience. Cureus. 2019; 11(12): e6268.